Publications by authors named "Erjing An"

Claim this Profile
F
First-line treatment options for PD-L1-negative lung adenocarcinoma: a real-world analysis.
Lijuan Chen, Jie Liu, Junfeng Lu, Xiufeng Hu, Erjing An, Yanqiu Zhao

Front Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Good response of cadonilimab (PD-1/CTLA-4 bi-specific antibody) to patients with advanced lung adenocarcinoma after immunotherapy resistance: A case report.
Erjing An, Junfeng Lu, Lijuan Chen

Asian J Surg· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis